Viskase Holdings Inc (ENZN) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Viskase Holdings inc   (ENZN)


Viskase Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENZN Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change 17890.22 %
Seq. Revenue Change 4.8 %
Revenue In Millions $90.13
Gross Profit Margin 12.31 %
Gross Profit Margin Total Ranking # 3169
Gross Profit In Millions $11.10
Y / Y Gross Profit Change -
Seq. Gross Profit Change 23.31 %


Commenting Second Quarter 2026 Gross Profit Margin
Viskase Holdings inc Gross Profit grew by 23.31 % in Q2 sequentially to 11 millions, while Revenue increased by 4.8 %, this led to improvement in the company's Gross Profit Margin to 12.31 % a new company high.


Observing second quarter 2026 results within Biotechnology & Pharmaceuticals industry 35 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3169.
Learn about Gross Margin
ENZN's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 36
Healthcare Sector # 430
Overall # 3145

Gross Profit Margin Statistics
High Average Low
12.31 % 8.55 % 2.86 %
(Jun 30 2026)   (Dec 31 2018)


ENZN Gross Income Trends • More of ENZN's Profitabilty Ratios • ENZN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ENZN's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ENZN's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ENZN's Competitors
Gross Profit Margin Profit Margin for Viskase Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for ENZN's Customers

You may also want to know
ENZN's Annual Growth Rates ENZN's Profitability Ratios ENZN's Asset Turnover Ratio ENZN's Dividend Growth
ENZN's Roe ENZN's Valuation Ratios ENZN's Financial Strength Ratios ENZN's Gross Profit Growth
ENZN's Roa ENZN's Inventory Turnover Ratio ENZN's Growth Rates ENZN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
X4 Pharmaceuticals Inc  32.63 %$ 0.783  Millions$ 2.400  Millions
Biomx Inc  29.22 %$ 0.097  Millions$ 0.332  Millions
Viskase Holdings inc   12.31 %$ 11.098  Millions$ 90.131  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.